Ids
stringlengths 36
36
| text
stringlengths 45
2.03k
| label
int64 0
1
|
|---|---|---|
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Ascites 1/116 (0.86%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Diarrhoea 3/116 (2.59%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Gingival bleeding 1/116 (0.86%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Intestinal haemorrhage 1/116 (0.86%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Nausea 2/116 (1.72%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Total: 24/115 (20.87%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Neutropenia 1/115 (0.87%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Thrombocytopenia 0/115 (0.00%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Acute myocardial infarction 0/115 (0.00%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Febrile Neutropenia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Retinopathy Hypertensive 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Febrile Infection 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Postoperative Wound Complication 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Cardiac Imaging Procedure Abnormal 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Malignant Melanoma In Situ 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Suicide Attempt 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Myocardial infarction 1/115 (0.87%) secondary trial: Dyspnoea 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Pericardial effusion 1/115 (0.87%) secondary trial: Total: 8/54 (14.81%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |
1b4f8828-cc7f-4831-a1c0-cc14e6ad23af | primary trial: Pericardial effusion 1/115 (0.87%) secondary trial: Anaemia 1/54 (1.85%) There were no completed suicides in either the primary trial or the secondary trial, however there was one attempt in cohort 1 of the secondary trial. | 1 |